home / stock / awh / awh news

AWH News and Press, Aspira Women's Health Inc. From 11/13/23

Stock Information
Company Name: Aspira Women's Health Inc.
Stock Symbol: AWH
Market: NASDAQ
Website: aspirawh.com
Menu
AWH AWH Quote AWH Short AWH News AWH Articles AWH Message Board
Get AWH Alerts

News, Short Squeeze, Breakout and More Instantly...
AWH - Aspira Women's Health GAAP EPS of -$0.48 beats by $0.03, revenue of $2.22M misses by $0.68M

2023-11-13 16:33:12 ET More on Aspira Women’s Health Aspira Women's Health CFO buys 2,246 shares in the company Seeking Alpha’s Quant Rating on Aspira Women’s Health Historical earnings data for Aspira Women’s Health Financial info...
AWH - Aspira Women's Health Reports Third Quarter 2023 Financial Results

Product revenue increased 9% to $2.2 million for the quarter, and 19% to $7.0 million year to date OvaSuite sales volume increased 5% to 5,783 units for the quarter, and 16% to 18,331 units year to date Third quarter cash utilization of $3.3 million, a decrease of 56% compared t...

AWH - Expected US Company Earnings on Monday, November 13th, 2023

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

AWH - Expected earnings - Aspira Women's Health Inc.

Aspira Women's Health Inc. (AWH) is expected to report $-0.43 for Q3 2023
AWH - Aspira Women's Health Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Crosswalk Medicare Reimbursement Rate for OvaWatch

The proposed rule would allow for OvaWatch SM to be reimbursed at the same rate as Ova1 ® at $897 per test and will become final following a brief public comment period AUSTIN, Texas, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“...

AWH - Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Monday, November 13, 2023

AUSTIN, Texas, Oct. 31, 2023 (GLOBE NEWSWIRE) --  Aspira Women’s Health Inc. (“Aspira”), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecologic diseases, today announced that the company will re...

AWH - Aspira Women's Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research

AUSTIN, Texas, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecolo...
AWH - Aspira Women's Health Establishes a New Clinical Advisory Board

AUSTIN, Texas, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecolo...

AWH - New to The Street Announces Six Business Interviews on its 524th Show, Airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT

NEW YORK, Oct. 20, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street , a national TV show, announces episode 524th airing on the Fox Business Network , Monday, October 23, 2023, at 10:30 PM PT. New to The Street's 524th TV episode line-up features the following ...

AWH - Aspira Women's Health to Present at the BioVenture Nexus Conference

AUSTIN, Texas, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecologic diseases, ...
Previous 10 Next 10